Board of Directors

Steven Sherman

Chairman of the Board

Mr. Sherman has served on the Board of Directors of Ekso Bionics since December 2013. Since 1988, Mr. Sherman has been a member of Sherman Capital Group, a Merchant Banking organization with a portfolio of private and public investments. In addition to Ekso Bionics, Mr. Sherman is currently Chairman of Purple Wave Inc. Mr. Sherman is a founder of Novatel Wireless, Inc., Vodavi Communications Systems Inc. and Main Street and Main Inc. Previously, Mr. Sherman has served as a director of Telit; Chairman of Airlink Communications, Inc. until its sale to Sierra Wireless, Inc.; Chairman of Executone Information Systems; and as a director of Inter-Tel (Delaware) Incorporated.

Committees

Committee Role
Audit Committee Chair
Compensation Committee Member

Tom Looby

President and Chief Executive Officer

Tom is President and CEO of Ekso Bionics. He joined the company in April 2014 as the company’s Chief Marketing Officer, a role in which he led the development and execution of the company’s global rehabilitation marketing strategy. Prior to joining Ekso Bionics, Tom served as Senior Vice President and Chief Marketing Officer at Given Imaging, now part of Medtronic, where he was responsible for worldwide market development for PillCam® capsule endoscopy and other novel diagnostics technologies.  Tom has a BS from University of Notre Dame in Chemical Engineering and an MBA from the University of Dayton.

Dan Boren

Director

Mr. Boren has served on the Board of Directors of Ekso Bionics since April 2013. Since January 2013, Mr. Boren has served as the President of Corporate Development for the Chickasaw Nation. Prior to that role, Mr. Boren served as the elected representative of Oklahoma's 2nd Congressional District in the U.S. House of Representatives from 2005 through 2013. Before his election to the U.S. House of Representatives, Mr. Boren was elected to the Oklahoma House of Representatives from 2002 to 2004. Mr. Boren earned his B.S. in Economics at Texas Christian University and went on to obtain an M.B.A. at University of Oklahoma.

Committees

Committee Role
Nominating and Governance Committee Chair
Audit Committee Member

Marilyn Hamilton

Director

Ms. Hamilton has served on the Board of Directors of Ekso Bionics since January 2012. In 2009, Ms. Hamilton founded StimDesigns LLC, an early stage neurotechnology company where she has served as CEO from 2009 to present. In 2007, Ms. Hamilton launched Envision, a professional speaking and business consulting company, and has served as its CEO from 2007 to present. Prior to launching Envision, Ms. Hamilton co-founded Motion Designs Inc. in 1979, a manufacturing and marketing company pioneering innovating custom, ultra-lightweight Quickie wheelchairs where she served in various leadership positions until it was sold ultimately to Sunrise Medical Inc., where Ms. Hamilton served as Global VP. In 1990 Ms. Hamilton founded Winners on Wheels, a coed-scouting program for children in wheelchairs; in 2003 she co-founded Discovery through Design, raising awareness and funds for spinal cord injury research and paralyzed women's health; and for 9 years she served as a founding board member and current emeritus board member of The California Endowment, charged with expanding access to affordable, quality healthcare for underserved populations and to promote improvements in the health status of all Californians. Ms. Hamilton is currently an advisory board member of the National Center for Medical Rehabilitation Research at the National Institute of Health and has been a member of The Committee of 200 business women since 1993 whose mission is to foster, celebrate and advance women's leadership in private and public companies.

Committees

Committee Role
Nominating and Governance Committee Member

Howard Palefsky

Director

Howard Palefsky is a veteran in the healthcare industry who has extensive experience as an entrepreneur, CEO, board chair, director and investor in the life sciences, including medical devices. Mr. Palefsky is currently an active advisor or board member to multiple companies in the healthcare arena, including Olatec Therapeutics, Adigica Health, Life Sciences Alternative Funding and Victoria Capital Management. Previously, he was a managing director at Montreux Equity Partners as well as chairman and CEO of a Montreux portfolio company, NeurogesX. From 1978 to 1997, Mr. Palefsky was the chairman, president and CEO of Collagen Corporation, a pioneer in the aesthetic medicine field. Mr. Palefsky led Collagen from a pre-revenue, venture funded start up through numerous financings, product approvals, international launches and profitability, all of which culminated in Collagen's initial public offering. He then managed the creation of Collagen's spin-off companies and each of their ultimate acquisitions.

Jack Peurach

Director

Mr. Peurach has served on the Board of Directors of Ekso Bionics since January 2012. Since 2011, Mr. Peurach has been the Executive Vice President, Products for SunPower Corp (NASDAQ: SPWR), where he is responsible for all aspects of SunPower’s PV modules and residential, commercial and utility PV systems. Prior to this role, from 2009 to 2011, Mr. Peurach served as Executive Vice President, Research and Development for SunPower, where he led the research and development efforts of the PV Cells, Modules and Systems. From 2008 to 2009, Mr. Peurach was the Vice President of the Advanced Product Development Group, and from 2007 to 2008, Mr. Peurach was the Senior Director of Product Development at SunPower. Prior to SunPower’s acquisition of PowerLight in 2007, Mr. Peurach served as PowerLight’s Vice President of Product Development. Earlier in his career, Mr. Peurach was a strategy consultant for Mercer Management Consulting and director of engineering at Berkeley Process Control, Inc. He holds a Bachelor of Science degree in mechanical engineering from Michigan State University, a Master of Science degree in mechanical engineering from the University of California, Berkeley, and a Master of Business administration, finance and entrepreneurship from the Wharton School, University of Pennsylvania.

Committees

Committee Role
Compensation Committee Chair
Nominating and Governance Committee Member

Stanley Stern

Director

Mr. Stern currently is Managing Partner of Alnitak Capital, which he founded in 2013 to provide Board level strategic advisory services, primarily in technology related industries. Before founding Alnitak, Mr. Stern was a Managing Director at Oppenheimer & Co. from 1995-2000 and from 2004 to 2013, where, among other positions, he led the firm's investment banking department and technology investment banking groups. Prior to joining Oppenheimer & Co, Mr. Stern held roles at Salomon Brothers, STI Ventures and C.E. Unterberg.

Mr. Stern is currently the Chairman of the Board of Audiocodes Inc., a leader in VOIP infrastructure equipment, and a member of the Board and Chairman of the Audit Committee of Foamix, Inc. Previously Mr. Stern was a member of the Board of Directors, member of the Audit Committee at Given Imaging and a Member of the Board of Directors, and Chairman of Audit Committee at Fundtech Inc., and Chairman of the Board of Tucows, Inc. Mr. Stern holds a B.A. in Economics and Accounting from City University of New York, Queens College, and an M.B.A. from Harvard University.

Committees

Committee Role
Audit Committee Member

Amy Wendell

Director

Amy is a senior global strategy and BD&L officer in the healthcare sector with an extensive transaction leadership background managing deals from inception through integration; including over 90 acquisitions, licensing, distribution deals, 35 divestitures, 20 equity investments, the industry's largest medical device spin and largest med-tech acquisition. She worked directly with Covidien's President and Board to make it the best performing large med tech company stock – doubling the Company's intrinsic value by focusing on restructuring the portfolio to deliver top line sustainable growth and enhanced margins. Amy was fully accountable for portfolio management, resource allocation and identification of new market opportunities, leveraging her deep institutional and device industry knowledge with experience in both developed and emerging markets, standard of care and early stage technologies.

Prior to Medtronic’s acquisition of Covidien in January 2015, Amy was Senior Vice President, Strategy & BD&L at Covidien PLC, where she led the company's strategic planning and portfolio management functions, as well as all business development initiatives including M&A, integrations, equity investments, divestitures, licensing, distribution, and market intelligence. In this role she was an integral player in the largest healthcare spin in history of $25 billion, the largest med-tech acquisition of $50 billion, and establishing Covidien Ventures, making ~$100 million of equity investments in early stage/start up companies. She also led her team to establish a disciplined portfolio management process that increased sales from low to mid-single digits, expanded gross margin 13% points and operating income 17% points, grew emerging markets to $1.6B in revenue, and was awarded "Strategic Buyer of the Year" by M&A Magazine in 2012.

Amy was previously Vice President, BD&L at Tyco Healthcare (Covidien’s predecessor company), where she was part of the leadership team that built the business from $600 million to $10 billion, with 80% of products in #1 or #2 market leadership positions; and increased international revenue from 10% to 40%.

Amy joined Covidien's predecessor company, Kendall Healthcare Products in 1986, and then worked through Tyco International's acquisition of Kendall in 1994 (Tyco Healthcare) and subsequent spin off from Tyco to form Covidien in 2007. During this transition she held expanding roles in engineering, product management and strategic business development.

Amy was recently elected to the Board of Directors of Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a pioneer in the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. Her prior Board experience includes extensive interaction with the Covidien Board of Directors, making proposals on all corporate transactions and influencing various strategic issues. She also is currently on the Por Cristo Board, a non-profit charitable medical service organization involved in health care work for at-risk women and children in Latin America.

She received her Bachelor of Science degree in Mechanical Engineering from Lawrence Institute of Technology (currently Lawrence Technological University); and her Master of Science degree in Biomedical Engineering from the University of Illinois.

Committees

Committee Role
Compensation Committee Member
Nominating and Governance Committee Member